Stockhouse

Slynd(TM) (Drospirenone) tablets, 4 mg Updated Website Launches for Patients and Physicians

FLORHAM PARK, N.J,, June 23, 2020 /PRNewswire/ -- Exeltis USA, Inc, a division of Insud Pharma, today announced the launch of the updated slynd.com, the website for Slynd™ (drospirenone) tablets 4 mg, ...
Medindia

Exeltis USA, Inc. Announces the Launch of Slynd™(drospirenone) tablets, 4 mg, the First and Only Progestin-Only Pill Providing Pregnancy Prevention with a 24-hour missed pill ...

FLORHAM PARK, N.J., Sept. 16, 2019 /PRNewswire/ -- Exeltis USA, Inc. a division of Insud Pharma (headquartered in Madrid, Spain) today announced the commercial launch of its oral contraceptive tablet ...
Medindia

Peer-Reviewed Publication Reinforces Safety and Efficacy of Slynd™ (Drospirenone) tablets, 4 mg

FLORHAM PARK, N.J., June 11, 2020 /PRNewswire/ -- Exeltis USA, Inc, a division of Insud Pharma, today released a physician and patient communication letter announcing a recent publication in Drugs of ...